Publié il y a 7 ans
July 2016: First out-licensing of the MuSiC proprietary software suite
Dezyme signs a first out-licensing contract with a top-3 industrial enzymes company to benchmarck against internal R&D data.
23
1
abonnés
Dezyme is a spin-off from the 3BIO (BIOtechnology, BIOprocesses and BIOinformatics) department of the Université Libre de Bruxelles, ULB, Belgium. The company in-creation is offering to the Life Sciences, chemical and biofuel industries expert know-how in optimizing important features (stability, solubility,...) of proteins of interest (enzymes, biocatalysts, monoclonal antibodies, vacines,...). Access to the company's know-how is ensured through the licensing of best in-class proprietary software of the MuSiC suite and / or via fee for service contracts covering in-silico optimization and in-vitro experimental validation. Fee for service contracts have already been clinched with a top 10 pharma and a top 3 vaccine companies. Licenses have also been purchased by a top 3 Industrial Enzyme company. More than 500 academic and university labs are also using the software on a daily basis for their research activities.
Publié il y a 7 ans
Dezyme signs a first out-licensing contract with a top-3 industrial enzymes company to benchmarck against internal R&D data.
Publié il y a 7 ans
Dezyme signs a second fee for service contract with a top-3 vaccine company to optimize 2 vaccine antigen candidates of interest.
Publié il y a 7 ans
Dezyme signs a first fee for service contract with a top-10 pharma to optimize 5 proteins of interest, tragets to develop new drugs in oncology
Il n'y a pas encore d'organisations dans le réseau.
984 membres